BioPharma Dive11h
Bioequivalence studies: the key to a successful new generic
A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...
North Carolina biotech sues to block copies of $400M drug
BioCryst Pharmaceuticals sues Hetero with claims of Orladeyo patent infringement. Orladeyo generated $437.7 million in revenue for BioCryst last year. BioCryst seeks court order to prevent FDA ...
Medical News Today12d
Losartan potassium, oral tablet
Generic drugs usually cost less than the brand-name ... Consider carrying it in the original prescription-labeled container. Do not put this medication in a car’s glove compartment or leave ...
Key diabetes drug to cost up to 90% less in a few days
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...